Dubai, UAE, January 27, 2014 – Varian Medical Systems (NYSE:VAR), the premier supplier of radiotherapy equipment and software in the Middle East, is demonstrating its full range of radiotherapy delivery systems and software at the Arab Health Congress taking place here this week. The Varian booth (Sheikh Saeed Hall 1, booth No. S1 – C40) features the company’s technology and products for radiotherapy, radiosurgery, brachytherapy, and proton therapy.
At the show, Varian is also announcing a collaboration with Mediclinic International to equip the new Mediclinic City Hospital North Wing radiotherapy department in Dubai, which is expected to start clinical treatments in late 2015.
Full Range of Products
The latest version of Varian’s TrueBeam™ platform for fast and precise radiotherapy and radiosurgery will be on display, showcasing new image-guidance and precise patient positioning capabilities such as the PerfectPitch™ six-degrees-of-freedom couch, giving clinicians more angles from which to deliver treatments.
Visitors to the Varian booth can also learn more about the company’s new Edge Radiosurgery™ treatment system, Varian’s first dedicated end-to-end solution for planning and delivering advanced radiosurgery treatments using new real-time tumor tracking technology and motion management capabilities.
Varian is also unveiling RapidPlan™ for Middle East customers, offering knowledge-based treatment planning capabilities aimed at helping to create complex RapidArc® volumetric modulated arc therapy (VMAT) and intensity-modulated radiotherapy (IMRT) treatment plans. RapidPlan software provides clinicians with standard of care models to use as a baseline for developing new RapidArc and IMRT treatment plans for their patients. RapidArc and IMRT are radiotherapy techniques that focus precisely on the tumor while minimizing exposure of surrounding healthy tissues.
"We're excited to introduce RapidPlan to our Middle East customers and look forward to developing many more tools designed to improve the quality and cost effectiveness of care,” says Rolf Staehelin, head of international marketing for Varian’s Oncology Systems business. “RapidPlan helps automate an important part of the treatment planning process and allows clinicians to access an extensive body of clinical experience while expediting often cumbersome, time-consuming processes."
At the Arab Health Congress, Varian and Mediclinic are announcing a collaboration that will make advanced treatments more available to cancer patients in the United Arab Emirates. Mediclinic, based in South Africa, is establishing a new radiotherapy center in Dubai and has selected Varian to equip the new facility with state-of-the-art radiotherapy treatment systems and software.
“We are pleased to have been selected to partner with Mediclinic in Dubai,” adds Rolf Staehelin. “Varian is the global leader in integrated radiotherapy systems with a strong presence throughout the Middle East region and we are excited to be able to increase access to advanced treatments for the people of Dubai and the wider UAE.”
Devices presented in this press release may not be cleared or available in your market. Please verify the current status with your local Varian representative.
About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 6,400 people who are located at manufacturing sites in North America, Europe, and China and 72 sales and support offices around the world. For more information, visit http://www.varian.com or follow us on Twitter.